Skip to main content
King International Investment Limited logo

King International Investment Limited — Investor Relations & Filings

Ticker · 928 HKEX Financial and insurance activities
Open in API
Filings indexed 1,068 across all filing types
Latest filing 2026-04-26 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 928

About King International Investment Limited

https://www.kinginternational.hk

King International Investment Limited operates as an investment holding company with diversified operating segments. The core business areas encompass the provision of healthcare products and specialized medical services, alongside activities in money lending, securities trading and investment, and liquor distribution. Within the healthcare segment, the company specializes in advanced diagnostic services, including genetic testing, comprehensive health data analysis, tumor gene detection, auxiliary diagnosis support, and personalized medication guidance. The company maintains a significant presence in the People's Republic of China and Hong Kong, while also engaging in trade across major international markets such as Australasia, Africa, and Eastern Europe.

Recent filings

Filing Released Lang Actions
List of Directors and their Role and Function
Board/Management Information Classification · 1% confidence The document is an announcement of the company’s board composition and committee appointments with effect from a specific date. It details the directors, their roles, and committee memberships, indicating a change or confirmation of board/management structure. This fits the definition for Board/Management Information (MANG).
2026-04-26 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE OF COMPOSITION OF BOARD COMMITTEES
Board/Management Information Classification · 1% confidence The document is a corporate announcement by King International Investment Limited regarding the appointment of an independent non-executive director and changes to the composition of board committees. It contains biographical details of the newly appointed director, committee assignments, and compliance with listing rules. This fits the definition of Board/Management Information (announcement of changes in the company's board of directors or senior management).
2026-04-26 English
WITHDRAWAL OF THE WINDING-UP PETITION
Legal Proceedings Report Classification · 1% confidence The document is a public announcement regarding the withdrawal of a winding‐up petition filed against the company, referencing Listing Rules and a court order – clearly an update on significant legal proceedings. It is not a financial report, earnings release, or capital change notice but specifically addresses a legal matter. Therefore, it fits the “Legal Proceedings Report” category.
2026-04-14 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is a standardized HKEX Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” detailing monthly movements in share capital, issued shares, treasury shares and confirmations under the Exchange Listing Rules. It is not an earnings release, interim or annual report, proxy or capital financing notice, but rather a routine regulatory compliance filing. It does not announce a specific event like a share issue or dividend, therefore it falls into the general regulatory filings fallback category.
2026-04-02 English
INSIDE INFORMATION WINDING-UP PETITION
Legal Proceedings Report Classification · 1% confidence The document is an official announcement regarding a 'Winding-up Petition' filed against the company. It details the legal nature of the petition, the potential effects on share transfers, and the company's intended legal response. This falls under the category of significant legal proceedings and regulatory disclosures regarding the company's status, which is best classified as a Legal Proceedings Report (LTR).
2026-03-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2026
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. Since it is a recurring regulatory filing regarding share capital and securities movements that does not fit into specific categories like 'Share Issue' (which is for specific events) or 'Transaction in Own Shares' (which is for specific buybacks), it is best classified as a Regulatory Filing (RNS).
2026-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.